ATE174932T1 - Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen - Google Patents
Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE174932T1 ATE174932T1 AT92118271T AT92118271T ATE174932T1 AT E174932 T1 ATE174932 T1 AT E174932T1 AT 92118271 T AT92118271 T AT 92118271T AT 92118271 T AT92118271 T AT 92118271T AT E174932 T1 ATE174932 T1 AT E174932T1
- Authority
- AT
- Austria
- Prior art keywords
- compositions containing
- vip
- modified
- pharmaceutical compositions
- fragments
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 abstract 4
- 102000055135 Vasoactive Intestinal Peptide Human genes 0.000 abstract 3
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000001413 amino acids Chemical group 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 101000953492 Homo sapiens Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Proteins 0.000 abstract 1
- 102100037739 Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 Human genes 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL9992491A IL99924A (en) | 1991-10-31 | 1991-10-31 | Derivatives of structurally modified vip and pharmaceutical compositions containing them |
| CN93101710A CN1060178C (zh) | 1991-10-31 | 1993-01-15 | 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE174932T1 true ATE174932T1 (de) | 1999-01-15 |
Family
ID=36792814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92118271T ATE174932T1 (de) | 1991-10-31 | 1992-10-26 | Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0540969B1 (de) |
| JP (1) | JP3311800B2 (de) |
| KR (1) | KR100240434B1 (de) |
| CN (1) | CN1060178C (de) |
| AT (1) | ATE174932T1 (de) |
| DE (1) | DE69227979T2 (de) |
| IL (1) | IL99924A (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447912A (en) * | 1989-09-18 | 1995-09-05 | Senetek, Plc | Erection-inducing methods and compositions |
| IL105061A (en) * | 1993-03-16 | 2000-11-21 | Yeda Res & Dev | Pharmaceutical compositions for the treatment of neurodegenerative diseases comprising VIP analogues and fragments thereof |
| US5565424A (en) * | 1994-02-07 | 1996-10-15 | Ramot - University Authority For Applied Research And Industrial Development Ltd. | Superactive VIP antagonists |
| IL118003A0 (en) * | 1996-04-23 | 1996-08-04 | Yeda Res & Dev | Novel vip fragments and pharmaceutical compositions comprising them |
| IL136631A0 (en) * | 2000-06-07 | 2001-06-14 | Yeda Res & Dev | Vip-related peptides for treatment of skin disordes |
| FR2854897B1 (fr) * | 2003-05-12 | 2007-05-04 | Sederma Sa | Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane. |
| US8841255B2 (en) | 2005-12-20 | 2014-09-23 | Duke University | Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| US8178495B2 (en) | 2008-06-27 | 2012-05-15 | Duke University | Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4605641A (en) * | 1984-10-09 | 1986-08-12 | Hoffmann-La Roche Inc. | Synthetic vasoactive intestinal peptide analogs |
| SE8702520D0 (sv) * | 1987-06-16 | 1987-06-16 | Kabigen Ab | Mammal intestine hormone precursor |
| IL87055A (en) * | 1988-07-08 | 1994-06-24 | Illana Gozes | Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them |
| DK0463450T3 (da) * | 1990-06-26 | 1994-06-27 | Sanwa Kagaku Kenkyusho Co | Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf |
-
1991
- 1991-10-31 IL IL9992491A patent/IL99924A/en not_active IP Right Cessation
-
1992
- 1992-10-26 AT AT92118271T patent/ATE174932T1/de not_active IP Right Cessation
- 1992-10-26 DE DE69227979T patent/DE69227979T2/de not_active Expired - Fee Related
- 1992-10-26 EP EP92118271A patent/EP0540969B1/de not_active Expired - Lifetime
- 1992-10-30 KR KR1019920020187A patent/KR100240434B1/ko not_active Expired - Fee Related
- 1992-11-02 JP JP33485092A patent/JP3311800B2/ja not_active Expired - Fee Related
-
1993
- 1993-01-15 CN CN93101710A patent/CN1060178C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IL99924A0 (en) | 1992-08-18 |
| CN1060178C (zh) | 2001-01-03 |
| EP0540969A3 (de) | 1994-08-03 |
| KR100240434B1 (ko) | 2000-01-15 |
| DE69227979T2 (de) | 1999-07-01 |
| IL99924A (en) | 1995-12-31 |
| DE69227979D1 (de) | 1999-02-04 |
| JPH06206898A (ja) | 1994-07-26 |
| JP3311800B2 (ja) | 2002-08-05 |
| CN1089950A (zh) | 1994-07-27 |
| EP0540969A2 (de) | 1993-05-12 |
| EP0540969B1 (de) | 1998-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI860153A0 (fi) | Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning. | |
| DK0929574T3 (da) | Modulatorer af beta-amyloidpeptidaggregering, som omfatter D-aminosyrer | |
| RU94046251A (ru) | Глюкагоноподобный пептид и производные инсулино-тропина, способ получений, фармацевтические композиции, способы лечения диабета | |
| DK197186A (da) | Fluorescerende mono-, di- eller polyamider af en aminomonocarboxylsyre og en tetrapyrrol indeholdende mindst tre carboxylgrupper | |
| DK0792287T3 (da) | Peptidanaloger af humant basisk myelinprotein | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| ES2071815T3 (es) | Analogos de delecion de los peptidos conocidos como magaininas. | |
| ATE174932T1 (de) | Modifizierte vip-derivate und sie enthaltende pharmazeutische zusammensetzungen | |
| DE59010316D1 (de) | Neue Insulinderivate, Verfahren zu deren Herstellung, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung | |
| GR880300151T1 (en) | Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it | |
| DK482185D0 (da) | Peptider, deres fremstilling og anvendelse som laegemidler | |
| ES2169037T3 (es) | Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis. | |
| DK0463053T3 (da) | Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener | |
| ATE138098T1 (de) | Analoga von menschlichem wachstumshormon und ihre verwendung | |
| ATE93527T1 (de) | Peptide und deren benutzung. | |
| ES2058290T3 (es) | Analogos de somatostatina terapeuticos. | |
| DK0422215T3 (da) | Antibakterielle peptider og antimalariapeptider | |
| AR018532A1 (es) | Proteinas sustancialmente puras que contienen analogos de la beta-lipoproteina (blt); aislados de acidos nucleicos que codifican dichas proteinas yformulaciones farmaceuticas que comprenden las proteinas | |
| DE3162674D1 (en) | A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it | |
| DK0423326T3 (da) | Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta | |
| SE9402332D0 (sv) | Igf-1 | |
| NO933628D0 (no) | Fremgangsmaate og blanding for behandling av herpes-infeksjoner | |
| IT1243778B (it) | Derivati salini dell'acido tauroursodesossicolico, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| NO922229L (no) | Peptid derivativ, fremgangsmaate til fremstilling av dissefarmasoeytiske preparater som inneholder disse og fremgangsmaate for behandling av glaucoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |